Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Interleukin-6 may play a role in causing alopecia areata.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

Macrophages help activate hair follicle stem cells, affecting hair growth and skin repair.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Platelet rich plasma is an effective treatment for alopecia areata.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.